Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiwon Oh

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|January 18, 2019
Multisite reliability and repeatability of an advanced brain MRI protocolDaniel L Schwartz, Ian Tagge, Katherine Powers, et al.
Environment International|November 15, 2025
Prenatal organophosphate ester exposure and epigenetic changes at birth: a characterization of the methylome in the ECHO cohortRose Schrott, Jennifer L Ames, Emily S Barrett, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialistsGustavo Saposnik, Sanketh Andhavarapu, Óscar Fernández, et al.
The Lancet. Neurology|October 9, 2012
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studyShiv Saidha, Elias S Sotirchos, Mohamed A Ibrahim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2024
Choroid plexus volume differentiates MS from its mimicsElle Levit, Zheng Ren, Virgilio Gonzenbach, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 19, 2026
Myelin damage in radiologically isolated syndrome is associated with decreased processing speedOlivia Kalau, Poljanka Johnson, Jiwon Oh, et al.
Multiple Sclerosis and Related Disorders|June 5, 2020
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 yearsJiwon Oh, Anat Achiron, Elisabeth G Celius, et al.
The Lancet. Neurology|July 19, 2025
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension studyAmit Bar-Or, Michal Dufek, Hrvoje Budincevic, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b studyGavin Giovannoni, Laura Airas, Riley Bove, et al.
Environmental Science & Technology|June 30, 2025
Exposures to Contemporary and Emerging Chemicals among Children Aged 2 to 4 Years in the United States Environmental Influences on the Child Health Outcome (ECHO) CohortJiwon Oh, Jessie P Buckley, Kurunthachalam Kannan, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Journal of Magnetic Resonance Imaging : JMRI|January 18, 2019
Multisite reliability and repeatability of an advanced brain MRI protocolDaniel L Schwartz, Ian Tagge, Katherine Powers, et al.
Environment International|November 15, 2025
Prenatal organophosphate ester exposure and epigenetic changes at birth: a characterization of the methylome in the ECHO cohortRose Schrott, Jennifer L Ames, Emily S Barrett, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialistsGustavo Saposnik, Sanketh Andhavarapu, Óscar Fernández, et al.
The Lancet. Neurology|October 9, 2012
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studyShiv Saidha, Elias S Sotirchos, Mohamed A Ibrahim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2024
Choroid plexus volume differentiates MS from its mimicsElle Levit, Zheng Ren, Virgilio Gonzenbach, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 19, 2026
Myelin damage in radiologically isolated syndrome is associated with decreased processing speedOlivia Kalau, Poljanka Johnson, Jiwon Oh, et al.
Multiple Sclerosis and Related Disorders|June 5, 2020
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 yearsJiwon Oh, Anat Achiron, Elisabeth G Celius, et al.
The Lancet. Neurology|July 19, 2025
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension studyAmit Bar-Or, Michal Dufek, Hrvoje Budincevic, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b studyGavin Giovannoni, Laura Airas, Riley Bove, et al.
Environmental Science & Technology|June 30, 2025
Exposures to Contemporary and Emerging Chemicals among Children Aged 2 to 4 Years in the United States Environmental Influences on the Child Health Outcome (ECHO) CohortJiwon Oh, Jessie P Buckley, Kurunthachalam Kannan, et al.
Pageof 27